Logo image of ALISP.PA

ISPD NETWORK (ALISP.PA) Stock Fundamental Analysis

Europe - EPA:ALISP - ES0109429037 - Common Stock

1.88 EUR
-0.03 (-1.57%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

3

ALISP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 62 industry peers in the Media industry. ALISP has a bad profitability rating. Also its financial health evaluation is rather negative. ALISP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALISP has reported negative net income.
ALISP had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALISP reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ALISP reported negative operating cash flow in multiple years.
ALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

ALISP's Return On Assets of -0.60% is on the low side compared to the rest of the industry. ALISP is outperformed by 62.90% of its industry peers.
ALISP has a Return On Equity of -9.85%. This is in the lower half of the industry: ALISP underperforms 67.74% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.85%, ALISP is in line with its industry, outperforming 41.94% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALISP is significantly above the industry average of 8.09%.
The 3 year average ROIC (13.74%) for ALISP is well above the current ROIC(2.85%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.6%
ROE -9.85%
ROIC 2.85%
ROA(3y)2.77%
ROA(5y)1.73%
ROE(3y)30.06%
ROE(5y)N/A
ROIC(3y)13.74%
ROIC(5y)14.58%
ALISP.PA Yearly ROA, ROE, ROICALISP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

ALISP has a Operating Margin of 0.45%. This is in the lower half of the industry: ALISP underperforms 66.13% of its industry peers.
ALISP's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 31.54%, ALISP is doing worse than 72.58% of the companies in the same industry.
ALISP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.45%
PM (TTM) N/A
GM 31.54%
OM growth 3Y-61.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-7.49%
ALISP.PA Yearly Profit, Operating, Gross MarginsALISP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

2

2. Health

2.1 Basic Checks

ALISP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ALISP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALISP has more shares outstanding
ALISP has a worse debt/assets ratio than last year.
ALISP.PA Yearly Shares OutstandingALISP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ALISP.PA Yearly Total Debt VS Total AssetsALISP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.29 indicates that ALISP is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.29, ALISP is doing good in the industry, outperforming 75.81% of the companies in the same industry.
ALISP has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.10, ALISP perfoms like the industry average, outperforming 43.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 2.29
ROIC/WACC0.45
WACC6.28%
ALISP.PA Yearly LT Debt VS Equity VS FCFALISP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.95 indicates that ALISP may have some problems paying its short term obligations.
With a Current ratio value of 0.95, ALISP perfoms like the industry average, outperforming 46.77% of the companies in the same industry.
ALISP has a Quick Ratio of 0.95. This is a bad value and indicates that ALISP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.95, ALISP is in line with its industry, outperforming 56.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ALISP.PA Yearly Current Assets VS Current LiabilitesALISP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

ALISP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -116.55%.
Looking at the last year, ALISP shows a quite strong growth in Revenue. The Revenue has grown by 11.47% in the last year.
ALISP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.98% yearly.
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.22%
Revenue 1Y (TTM)11.47%
Revenue growth 3Y13.88%
Revenue growth 5Y43.98%
Sales Q2Q%6.35%

3.2 Future

Based on estimates for the next years, ALISP will show a very strong growth in Earnings Per Share. The EPS will grow by 216.23% on average per year.
The Revenue is expected to grow by 4.86% on average over the next years.
EPS Next Y900%
EPS Next 2Y216.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.17%
Revenue Next 2Y10.79%
Revenue Next 3Y6.89%
Revenue Next 5Y4.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALISP.PA Yearly Revenue VS EstimatesALISP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
ALISP.PA Yearly EPS VS EstimatesALISP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

ALISP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 9.13 indicates a reasonable valuation of ALISP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALISP indicates a somewhat cheap valuation: ALISP is cheaper than 70.97% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. ALISP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9.13
ALISP.PA Price Earnings VS Forward Price EarningsALISP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALISP indicates a slightly more expensive valuation: ALISP is more expensive than 67.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.35
ALISP.PA Per share dataALISP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALISP's earnings are expected to grow with 216.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y216.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALISP!.
Industry RankSector Rank
Dividend Yield N/A

ISPD NETWORK

EPA:ALISP (9/18/2025, 7:00:00 PM)

1.88

-0.03 (-1.57%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-29 2025-07-29
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.99M
Analysts86.67
Price Target5.15 (173.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-14.89%
EPS NY rev (3m)-14.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.13
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 5.83
P/tB N/A
EV/EBITDA 19.35
EPS(TTM)-0.03
EYN/A
EPS(NY)0.21
Fwd EY10.96%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS10.48
BVpS0.32
TBVpS-0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -9.85%
ROCE 3.88%
ROIC 2.85%
ROICexc 4.45%
ROICexgc N/A
OM 0.45%
PM (TTM) N/A
GM 31.54%
FCFM N/A
ROA(3y)2.77%
ROA(5y)1.73%
ROE(3y)30.06%
ROE(5y)N/A
ROIC(3y)13.74%
ROIC(5y)14.58%
ROICexc(3y)49.31%
ROICexc(5y)157.45%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.7%
ROCE(5y)19.84%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-80.84%
ROICexc growth 5YN/A
OM growth 3Y-61.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-7.49%
F-Score1
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA 2.7
Cap/Depr 123.02%
Cap/Sales 0.99%
Interest Coverage 1.02
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 2.29
F-Score1
WACC6.28%
ROIC/WACC0.45
Cap/Depr(3y)110.41%
Cap/Depr(5y)81.37%
Cap/Sales(3y)0.96%
Cap/Sales(5y)0.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.22%
EPS Next Y900%
EPS Next 2Y216.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.47%
Revenue growth 3Y13.88%
Revenue growth 5Y43.98%
Sales Q2Q%6.35%
Revenue Next Year11.17%
Revenue Next 2Y10.79%
Revenue Next 3Y6.89%
Revenue Next 5Y4.86%
EBIT growth 1Y-87.83%
EBIT growth 3Y-55.63%
EBIT growth 5YN/A
EBIT Next Year200%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.15%
OCF growth 3YN/A
OCF growth 5YN/A